These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 22290178)

  • 21. Unraveling the molecular mechanisms behind the metabolic basis of sporadic Alzheimer's disease.
    Erol A
    J Alzheimers Dis; 2009; 17(2):267-76. PubMed ID: 19221404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxidative stress--mediated alterations in glucose dynamics in a genetic animal model of type II diabetes.
    Bitar MS; Al-Saleh E; Al-Mulla F
    Life Sci; 2005 Sep; 77(20):2552-73. PubMed ID: 15936776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular and metabolic alterations in the hippocampus caused by insulin signalling dysfunction and its association with cognitive impairment during aging and Alzheimer's disease: studies in animal models.
    Calvo-Ochoa E; Arias C
    Diabetes Metab Res Rev; 2015 Jan; 31(1):1-13. PubMed ID: 24464982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin resistance in the brain: an old-age or new-age problem?
    Williamson R; McNeilly A; Sutherland C
    Biochem Pharmacol; 2012 Sep; 84(6):737-45. PubMed ID: 22634336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Shared links between type 2 diabetes mellitus and Alzheimer's disease: A review.
    Mittal K; Katare DP
    Diabetes Metab Syndr; 2016; 10(2 Suppl 1):S144-9. PubMed ID: 26907971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered regulation of brain glucose metabolism as a cause of neurodegenerative disorders?
    Blum-Degen D; Frölich L; Hoyer S; Riederer P
    J Neural Transm Suppl; 1995; 46():139-47. PubMed ID: 8821049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Central insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer's disease.
    Velazquez R; Tran A; Ishimwe E; Denner L; Dave N; Oddo S; Dineley KT
    Neurobiol Aging; 2017 Oct; 58():1-13. PubMed ID: 28688899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comorbidity Analysis between Alzheimer's Disease and Type 2 Diabetes Mellitus (T2DM) Based on Shared Pathways and the Role of T2DM Drugs.
    Karki R; Kodamullil AT; Hofmann-Apitius M
    J Alzheimers Dis; 2017; 60(2):721-731. PubMed ID: 28922161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-sugar diets, type 2 diabetes and Alzheimer's disease.
    Moreira PI
    Curr Opin Clin Nutr Metab Care; 2013 Jul; 16(4):440-5. PubMed ID: 23657152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review article: diabetes and atherosclerosis--running on a common road.
    Federici M; Lauro R
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():11-5. PubMed ID: 16225464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modeling sporadic Alzheimer's disease: the insulin resistant brain state generates multiple long-term morphobiological abnormalities including hyperphosphorylated tau protein and amyloid-beta.
    Salkovic-Petrisic M; Osmanovic J; Grünblatt E; Riederer P; Hoyer S
    J Alzheimers Dis; 2009; 18(4):729-50. PubMed ID: 19661616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dementia, diabetes, Alzheimer's disease, and insulin resistance in the brain: progress, dilemmas, new opportunities, and a hypothesis to tackle intersecting epidemics.
    Kuljiš RO; Salković-Petrišić M
    J Alzheimers Dis; 2011; 25(1):29-41. PubMed ID: 21335659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain insulin signalling in the regulation of energy balance and peripheral metabolism.
    Diamant M
    Ideggyogy Sz; 2007 Mar; 60(3-4):97-108. PubMed ID: 17451048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders.
    Profenno LA; Porsteinsson AP; Faraone SV
    Biol Psychiatry; 2010 Mar; 67(6):505-12. PubMed ID: 19358976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes.
    Gupta A; Bisht B; Dey CS
    Neuropharmacology; 2011 May; 60(6):910-20. PubMed ID: 21277873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial dysfunction leads to impairment of insulin sensitivity and adiponectin secretion in adipocytes.
    Wang CH; Wang CC; Huang HC; Wei YH
    FEBS J; 2013 Feb; 280(4):1039-50. PubMed ID: 23253816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic defects shared by Alzheimer's disease and diabetes: A focus on mitochondria.
    Carvalho C; Moreira PI
    Curr Opin Neurobiol; 2023 Apr; 79():102694. PubMed ID: 36842275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucose metabolism and insulin receptor signal transduction in Alzheimer disease.
    Hoyer S
    Eur J Pharmacol; 2004 Apr; 490(1-3):115-25. PubMed ID: 15094078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular and Molecular Mechanisms of Dementia: Decoding the Causal link of Diabetes Mellitus in Alzheimer's Disease.
    Rasool M; Malik A; Waquar S; Zaheer A; Asif M; Iqbal Z; Gauthaman K; Kamal MA; Pushparaj PN
    CNS Neurol Disord Drug Targets; 2021; 20(7):602-612. PubMed ID: 33583389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alzheimer's disease: Is this a brain specific diabetic condition?
    Rani V; Deshmukh R; Jaswal P; Kumar P; Bariwal J
    Physiol Behav; 2016 Oct; 164(Pt A):259-67. PubMed ID: 27235734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.